Difference between revisions of "WSI24-156-Case-3"
From MGH Learn Pathology
(Creating page) |
(Added status template) |
||
| Line 16: | Line 16: | ||
|requisition= | |requisition= | ||
|reasonCode=35M with nasopharyngeal mass | |reasonCode=35M with nasopharyngeal mass | ||
| − | |||
|occurrenceDateTime=2024-08-13 12:00:00-04:00 | |occurrenceDateTime=2024-08-13 12:00:00-04:00 | ||
|authoredOn=2024-08-12 11:34:58.143603+00:00 | |authoredOn=2024-08-12 11:34:58.143603+00:00 | ||
| Line 23: | Line 22: | ||
Note: Immunohistochemistry shows the tumor cells to be positive for keratin 5/6, p40, and keratin MNF116 with preserved expression of INI1 and BRG1. The Ki67 proliferation index is 50%. In situ hybridization for EBER is diffusely positive. The tumor cells are negative for Sox10, NKX2.2, Desmin, NUT, P16, and synaptophysin." | Note: Immunohistochemistry shows the tumor cells to be positive for keratin 5/6, p40, and keratin MNF116 with preserved expression of INI1 and BRG1. The Ki67 proliferation index is 50%. In situ hybridization for EBER is diffusely positive. The tumor cells are negative for Sox10, NKX2.2, Desmin, NUT, P16, and synaptophysin." | ||
| − | |||
}} | }} | ||
{{Media | {{Media | ||
| Line 33: | Line 31: | ||
|reasonCode=H&E | |reasonCode=H&E | ||
|basedOn=WSI24-156-Case-3 | |basedOn=WSI24-156-Case-3 | ||
| + | }} | ||
| + | {{status | ||
| + | |status=active | ||
| + | |requester=Njc35 | ||
| + | |authoredOn=2024-08-12 11:34:58.143603+00:00 | ||
}} | }} | ||
Latest revision as of 16:05, August 30, 2024
